Lantheus Holdings Inc at UBS Global Healthcare Conference Transcript
I'm John Sourbeer, UBS' Life Sciences, Diagnostic Tools and Pharma Services analysts. We're -- our next presentation here, we have Lantheus. We're going to do a little bit of a presentation and then some Q&A.
Starting off, we have President and CEO, Mary Anne Heino. And then we have Robert Marshall, CEO and Treasurer. Mary Anne, would you like to get started?
Yes. Yes. Good morning, everyone, and thank you for attending. We look forward to talking with you this morning about Lantheus. I'll take a little while to talk to you about our products and what we're trying to achieve with them. And then Bob will bring you up to date on our most recent financials and a look at our strategic goals for the company.
So Mark, if you move forward, as always, I have to offer you our safe harbor statement for any statements we might make today that may be inferred as your right or your privilege
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |